Endoscopic Treatment of Bronchial Carcinoid Tumors

Carcinoid Tumor Clinical Trial

Official title:

Feasibility and Therapeutic Method of Endoscopic Treatment of Bronchial Carcinoid Tumors: 22 Years Experience of Saint-Etienne

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03723499
• Other study ID #: IRBN812018/CHUSTE
• Status: Completed
• Start date: November 1995
• Est. completion date: December 2017

Study information

• Verified date: October 2018
• Source: Centre Hospitalier Universitaire de Saint Etienne
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Carcinoid tumors of the lung are considered to be a low-grade malignancy. Surgical resection is considered the standard approach. Recent data has shown that a complete endoscopic treatment could be considered. An endoscopic treatment is can be a alternative to invasive surgery.

Description:

The objective of this study is to evaluate the feasibility and therapeutic method of endoscopic treatment of bronchial carcinoid tumors.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 70
• Est. completion date: December 2017
• Est. primary completion date: December 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients treated by endoscopic approach for a carcinoid tumor at the University Hospital Centre of Saint-Etienne between November 1995 to December 2017.

Exclusion Criteria:

• Patients treated for a recurrence of carcinoid tumor.

• Patients with metastatic disease.

Related Conditions & MeSH terms

• Carcinoid Tumor

Intervention

Other:
• Medical data collection
Medical data collection by medical record will be collected: demographics data, medical history, clinical symptoms, smoking, type of endoscopic method, complete treatment or not, type of surgeries if yes, anatomopathology of the injury and recurrence if yes

Locations

Country	Name	City	State
France	CHU de Saint-Etienne	Saint-Étienne

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Universitaire de Saint Etienne

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Complete endoscopic treatment	patients who have a complete endoscopic treatment	Month 1
Secondary	Type of endoscopic method used	Analysis type of endoscopic method used.	Month 1
Secondary	Tumor localization	Analysis the tumor localization.	Month 1
Secondary	Deadline before recurrence	Analysis the deadline before recurrence of the tumor.	10 years